These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 2043872

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma].
    Dini G, Garaventa A, Lanino E, Perin GP, Scarpati D, Viscoli C, Franchini E, Corvò R, Dallorso S, Cinollo G.
    Pediatr Med Chir; 1987; 9(1):1-7. PubMed ID: 3306621
    [Abstract] [Full Text] [Related]

  • 23. [Autologous bone marrow transplantation in pediatric cancer].
    Ohira M.
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2299-306. PubMed ID: 2260867
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission.
    Carella AM, Gaozza E, Santini G, Martinengo M, Pungolino E, Piatti G, Congiu A, Nati S, Carlier P, Giordano D.
    Bone Marrow Transplant; 1988 Nov; 3(6):537-41. PubMed ID: 3063322
    [Abstract] [Full Text] [Related]

  • 26. High-dose melphalan +/- total body irradiation and autologous hematopoietic stem cell rescue for adult patients with Ewing's sarcoma or peripheral neuroectodermal tumor.
    Stewart DA, Gyonyor E, Paterson AH, Arthur K, Temple W, Schachar NS, Klassen J, Brown C, Russell JA.
    Bone Marrow Transplant; 1996 Aug; 18(2):315-8. PubMed ID: 8864440
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Autologous bone marrow transplantation for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia--a comparison.
    Anderson CC, Goldstone AH, Linch DC, Jones HM, Franklin IM, Boughton BJ, Cawley JC, Richards JD.
    Bone Marrow Transplant; 1987 Feb; 1(3):271-9. PubMed ID: 3332138
    [Abstract] [Full Text] [Related]

  • 32. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan).
    Deconinck E, Cahn JY, Milpied N, Jouet JP, Vernant JP, Esperou H, Lioure B, Bordigoni P, Leblond V, Troussard X, Caillot D, Cordonnier JM, Hervé P.
    Bone Marrow Transplant; 1997 Nov; 20(9):731-5. PubMed ID: 9384474
    [Abstract] [Full Text] [Related]

  • 33. Application of autologous peripheral blood stem cell transplantation in children with malignant tumor.
    Tang S, Huang D, Wang J, Wei X, Ran C, Peng Y, Lu S, Zhang J.
    Chin Med J (Engl); 2001 Oct; 114(10):1098-101. PubMed ID: 11677775
    [Abstract] [Full Text] [Related]

  • 34. High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
    de Lima M, van Besien K, Gajewski J, Khouri I, Andersson B, Korbling M, Champlin R, Giralt S.
    Bone Marrow Transplant; 2000 Aug; 26(3):333-8. PubMed ID: 10967575
    [Abstract] [Full Text] [Related]

  • 35. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
    Bordigoni P, Esperou H, Souillet G, Pico J, Michel G, Lacour B, Reiffers J, Sadoun A, Rohrlich P, Jouet JP, Milpied N, Lutz P, Plouvier E, Cornu G, Vannier JP, Gandemer V, Rubie H, Gratecos N, Leverger G, Stephan JL, Boutard P, Vernant JP.
    Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290
    [Abstract] [Full Text] [Related]

  • 36. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D, Vassal G, Pondarré C, Bonnay M, Benhamou E, Couanet D, Plantaz D, Hartmann O.
    Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
    [Abstract] [Full Text] [Related]

  • 37. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C, Benyunes MC, Sale G, Beauchamp M, York A, Thompson JA, Buckner CD, Fefer A.
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [Abstract] [Full Text] [Related]

  • 38. [Allogeneic bone marrow transplantation in the treatment of acute leukemias of children. Study of 26 patients].
    Michel G, Maraninchi D, Perrimond H, Mascret B, Orsini A, Gastaut JA, Raybaud C, Blaise D, Demeocq F, Sebahoun G.
    Arch Fr Pediatr; 1986 Dec; 43(10):769-74. PubMed ID: 3548633
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C, Aversa F, Raymondi C, Marsella AR, Panizza BM, Perrucci E, Piro F, Maranzano E, Lupattelli M, Martelli MF, Latini P.
    Cancer J Sci Am; 1996 Dec; 2(6):330-4. PubMed ID: 9166553
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.